Narrowband UVB Phototherapy vs Topical Corticosteroids

Narrowband UVB may suit broader or recurring disease under supervision, while topical corticosteroids offer targeted anti-inflammatory treatment for defined areas.

Narrowband UVB is delivered in a clinic or supervised unit, with exposure adjusted as the skin responds. A topical corticosteroid is selected by strength and formulation, then applied to the affected area for the prescribed course. The right comparison is not simply light versus cream: body site, extent, diagnosis and previous treatment all change the balance.

Narrowband UVB may be discussed when several areas are involved, when applying medicine over a broad surface is difficult, or when the clinician wants a supervised non-tablet treatment approach. It can be especially relevant when the condition follows a recurring pattern and a planned course is realistic. The team will check light sensitivity, medicines and the skin’s reaction between sessions.

A topical corticosteroid may be suitable for a localised flare that needs direct anti-inflammatory treatment. The prescriber chooses a formulation and strength for the site, because thin skin such as the face or folds needs different caution from thicker skin. Use only the amount and duration advised, and keep follow-up if the area is not settling or repeatedly returns.

Narrowband UVB may cause dryness, redness or an overexposure reaction; tell the clinic about photosensitising medicines and protect the eyes as instructed. Topical corticosteroids can cause skin thinning and other local effects when the wrong strength, amount or duration is used, particularly on delicate sites. A painful, weeping or rapidly spreading rash may indicate infection or another problem needing review rather than stronger treatment.

Neither treatment is a complete answer when the diagnosis is unclear, infection is suspected, the disease is widespread and uncontrolled, or the skin keeps worsening despite an appropriate course. A clinician may need to adjust the diagnosis, add moisturising and trigger control, or consider another treatment class. A lesion that changes independently of the surrounding rash deserves separate assessment.

The clinician identifies the condition, maps the affected sites and checks whether the problem is a flare or a persistent pattern. They consider skin thickness, previous steroid exposure, light sensitivity, medicines and your ability to attend sessions or apply treatment accurately. They then set instructions for dose or application, explain warning signs and decide when the response should be reviewed. You can ask which areas should be treated and when to stop or change the plan.